MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by POYART, C. F.
Right arrow Articles by VULLIEMOZ, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by POYART, C. F.
Right arrow Articles by VULLIEMOZ, Y.

Molecular Pharmacology, Vol 4, 389-401, Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics

Inhbition of Activated Lipolysis by Acidosis

CLAUDE F. POYART 1, GABRIEL G. NAHAS 1, and YVONNE VULLIEMOZ 1

1 Department of Anesthesiology, College of Physicians and Surgeons, Columbia University, New York, New York 10032

Rat epididymal adipose tissue was incubated in Krebs-Ringer phosphate medium with 5% albumin without glucose and with glucagon, ACTH, norepinephrine, or cyclic 3',5'-AMP dibutyrate. pH of the medium was varied from 7.4 to 6.6. Glycerol release was measured and taken as the index of lipolytic activity. In a first series of experiments at pH 7.4, ACTH and glucagon-activated lipolysis was potentiated by increasing doses of theophylline. In a second series, with pH of the medium at 6.6, the lipolytic effects of these two hormones were significantly inhibited. When theophylline (10-2 M) was added in combination with optimal doses of the hormones, the rate of glycerol release was similar at normal and acid pH. These results were interpreted as indicating that H+ might exert its inhibitory effect on a common mechanism which results in cyclic 3',5'-AMP formation. This hypothesis was confirmed in a third series: when cyclic 3',5'-AMP dibutyrate (10-3 M) was added to the medium, similar glycerol release was found at pH 7.4 and 6.6. When combined with norepinephrine, cyclic 3',5'-AMP dibutyrate also reversed the inhibitory effects of acidosis. In a last series of experiments, it was shown that acidosis did not alter irreversibly the sites of action of the lipolytic agents. These results, when analyzed according to the drug-receptor theory, would indicate that acidosis might inhibit, at least in part, the different lipolytic drugs used in this study by hindering the formation of the drug-receptor complexes that activate lipolysis.

Note:
ACKNOWLEDGMENT We wish to thank Dr. Lubos Triner for his help and guidance in the planning of these experiments.

Submitted on November 6, 1967
Revised on March 27, 1968







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics